FLA‐IDA salvage chemotherapy combined with a seven‐day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia

Authors:

Abstract
No abstract available
Funding Information
  • Deutsche Forschungsgemeinschaft (HE 5240/5‐2, HE 5240/6‐1, HE 5240/6‐2)
  • Horizon 2020 (No. 638035)

This publication has 11 references indexed in Scilit: